Understanding T cell immunity in a type of blood vessel inflammation
T Cell Immunity in Giant Cell Arteritis
This study is looking at Giant Cell Arteritis (GCA) to understand why the immune system goes into overdrive and how that can cause serious problems, with the hope of finding new ways to help people with this condition.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Mayo Clinic Rochester NIH-funded |
| Lab location | 1 site (Rochester, United States) |
| Project ID | NIH-10992659 on NIH RePORTER |
What this research studies
This research investigates Giant Cell Arteritis (GCA), a serious condition that affects large blood vessels and can lead to severe complications like blindness and stroke. The study focuses on how certain immune checkpoints fail, leading to excessive T cell activity that contributes to the disease. By examining immune cells from GCA patients, researchers aim to uncover the mechanisms behind this autoimmune response and identify potential therapeutic targets. The approach includes detailed cellular mapping and functional experiments to understand the role of specific proteins in regulating immune responses.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Giant Cell Arteritis who are experiencing symptoms related to the condition.
Not a fit: Patients with other types of vasculitis or those not diagnosed with Giant Cell Arteritis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that better control T cell activity and reduce the risk of severe complications in patients with Giant Cell Arteritis.
How similar studies have performed: Previous research has shown promising results in understanding immune checkpoint failures in autoimmune diseases, suggesting that this approach may yield valuable insights.
Where this research is happening
Rochester, United States
- Mayo Clinic Rochester — Rochester, United States (Active)
Researchers
- Principal investigator: Weyand, Cornelia M. — Mayo Clinic Rochester
- Study coordinator: Weyand, Cornelia M.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.